Niramai

Bengaluru, India Founded: 2016 • Age: 10 yrs
Early breast cancer is detected using AI-based non-invasive thermal imaging.
Annual revenue $1.1M Latest available
Total funding $8.6M 9 rounds
Employees 51 Tracked headcount
Investors 22 Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About Niramai

Niramai is a company based in Bengaluru (India) founded in 2016 by Geetha Manjunath. Niramai has raised $8.63 million across 9 funding rounds from investors including HCG, Kotak Mahindra Bank and Murata Manufacturing. The company has 51 employees as of April 07, 2024. Niramai offers products and services including Thermalytix, Niramai SMILE 100, and Mythri. Niramai operates in a competitive market with competitors including Vayyar, CairnSurgical, UE LifeSciences, CMR Naviscan and Dune Medical, among others.

  • Headquarter Bengaluru, India
  • Employees 51 as on 07 Apr, 2024
  • Founders Geetha Manjunath
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Niramai Health Analytix Private Limited
  • Date of Incorporation 14 Jul, 2016
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.13 M (USD)
    63.94
    as on Mar 31, 2023
  • Net Profit
    -$1.42 M (USD)
    -4.24
    as on Mar 31, 2023
  • EBITDA
    -$1.82 M (USD)
    -11.57
    as on Mar 31, 2023
  • Total Equity Funding
    $8.63 M (USD)

    in 9 rounds

  • Latest Funding Round
    $625.32 K (USD), Series A

    Oct 21, 2023

  • Investors
    HCG

    & 21 more

  • Employee Count
    51

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Niramai

Niramai offers a comprehensive portfolio of products and services, including Thermalytix, Niramai SMILE 100, and Mythri.

Product name locked
Category locked
Primary

AI-powered thermal imaging for early breast cancer detection.

Product name locked
Category locked
Locked

FDA-cleared adjunct test for breast health analysis.

Product name locked
Category locked
Locked

Low-cost tool for rapid breast health risk assessment.

People of Niramai

Headcount 10-50
Employee Profiles 20
Employee Profiles
People
Siva Teja Kakileti
Principal Research Scientist & Director
People
Shireen Chopra
Head, HR
People
Kanchana Gopinath
Senior Manager Special Projects
People
Umar Farooq
Manager, Operations

Unlock access to complete

Funding Insights of Niramai

Niramai has successfully raised a total of $8.63M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $625.32 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Niramai

Niramai has secured backing from 22 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include HCG, Kotak Mahindra Bank and Murata Manufacturing.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Venture capital firm investing in early-stage startups in technology sectors.
Locked Locked Locked
Deep-tech venture capital investments in early-stage companies.
Locked Locked Locked
Indian fund focused on fintech, health, and climate initiatives.
Locked Locked Locked
Premium access

Investor details for Niramai

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Niramai

Investments
Premium access

Investment portfolio details for Niramai

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Niramai

Premium access

Detailed financials for Niramai

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Niramai Comparisons

Niramai Primary company
Description
Early breast cancer is detected using AI-based non-invasive ...
Location
Bengaluru, India
Founded Year
2016
Annual Revenue
$1.13 M (USD)
Net Profit
-$1.42 M (USD)
EBITDA
-$1.82 M (USD)
Employees
51
As of 2024
Premium access

Peer comparison for Niramai

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Niramai

Niramai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vayyar, CairnSurgical, UE LifeSciences, CMR Naviscan and Dune Medical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of 4D imaging sensors for cancer detection and other devices
Locked Locked Locked
Developer of 3D printed surgical guides for breast cancer treatment
Locked Locked Locked
Non-invasive devices for breast and cervical cancer screening are provided.
Locked Locked Locked
High-resolution PET scanners for breast imaging are developed and manufactured.
Locked Locked Locked
Intraoperative cancer detection devices are developed for real-time tissue assessment.
Premium access

Detailed competitors of Niramai

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Niramai

Premium access

Complete news archive for Niramai

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niramai

Niramai was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Niramai is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Geetha Manjunath is the current CEO of Niramai. They have also founded this company.

Niramai is a funded company, having raised a total of $8.63M across 9 funding rounds to date.

As of Apr 07, 2024, the latest employee count at Niramai is 51.

Annual revenue of Niramai is $1.13M as on Mar 31, 2023.

Niramai was established in 2016 in Bengaluru, India, within the health technology sector. An artificial intelligence-driven medical device is provided for non-invasive breast cancer screening. Thermal imaging technology is employed to assess chest temperature variations, achieving detection accuracy comparable to conventional approaches without radiation exposure. Operations include hospital and clinic-based screenings, at-home options, and community camp services across various settings.

Niramai's top competitors include CairnSurgical, UE LifeSciences and Micrima.

Niramai offers Thermalytix, Niramai SMILE 100, and Mythri.

Niramai has 22 investors. Key investors include HCG, Kotak Mahindra Bank, Murata Manufacturing, T-Hub, and Ankur Capital.

The valuation of Niramai is $24.09M as of Oct 2023.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available